Frontier Capital Management CO LLC Atea Pharmaceuticals, Inc. Transaction History
Frontier Capital Management CO LLC
- $10.2 Billion
- Q1 2024
Shares
2 transactions
Others Institutions Holding AVIR
# of Institutions
119Shares Held
49.6MCall Options Held
108KPut Options Held
327K-
Black Rock Inc. New York, NY9.24MShares$31.7 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA6.15MShares$21.1 Million0.71% of portfolio
-
Bml Capital Management, LLC Zionsville, IN5.54MShares$19 Million14.98% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.72MShares$16.2 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA4.08MShares$14 Million2.01% of portfolio
About Atea Pharmaceuticals, Inc.
- Ticker AVIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 83,258,600
- Market Cap $286M
- Description
- Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...